参考文献
［1］Davies H.Catheter-mounted valve for temporary relief of aortic insufficiency［J］.Lancet，1965，285：250.
［2］Andersen HR，Krnzdsen LL，Hasenkarn JM.Thansluminal implantation of artificial heart valves：description of a new expandable aortic valve and iniitial results with implantation by catheter technique in closed chest pigs［J］.Eur Heart J，1992，13：704-708.
［3］Lutter G，Kuklinski D，Berg G，et al.Percutaneous aortic valve replacement：an experimental study［J］.Thorac Cardiovasc Surg J，2002，123：768-776.
［4］Cribier，Eltchaninoff H，Borenstein N，et al.Transcatheter implantation of balloon expandable prosthetic heart valves.early results in an animal model［J］.Circulation，2001，104（Suppl Ⅱ）：1552.
［5］Bonhoeffer P，Boudjemline Y，Qureshi S A，et al.Percutaneous insertion of the pulmonary valve［J］.J Am Coll Cardiol，2002，39：1664-1669.
［6］Crihier A，Eltchanirioff H，Bash A，et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis：first hunan case description［J］.Circulation，2002，106（24）：3006-3008.
［7］Grube E，Laborde JC，Gickmann B，et al.First report on a human percntaneons translnrninal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis［J］.Catheter Cardiovasc lnterv，2005，66（4）：465-469.
［8］Leon MB，Smith CR，Mack M，et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery［J］.N Engl J Med，2010，363：1597-1607.
［9］Smith CR，Leon MB，Mack MJ，et al.Transcatheter versus surgical aortic-valve replacement in high-risk patients［J］.N Engl J M ed，2011，364：2187-2198.
［10］Leon MB，Smith CR，Mack MJ，et al.Partner 2 Investigators.Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients［J］.N Engl J Med，2016，374（17）：1609-1620.(https://www.daowen.com)
［11］Reardon MJ，Van Mieghem NM，Popma JJ，et al.Surtavi Investigators.Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients［J］.N Engl J Med，2017，376（14）：1321-1331.
［12］Kodali S，Thourani VH，White J，et al.Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable，high-risk and intermediate-risk patients with aortic stenosis［J］.Eur Heart J，2016，37：2252-2262.
［13］Thourani VH，Kodali S，Makkar RR，et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients：a propensity score analysis［J］.Lancet，2016，387：2218-2225.
［14］Sorajja P，Kodali S，Reardon M，et al.Outcomes in the commercial use of self-expanding prostheses in transcatheter aortic valve replacement：a comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.Paper presented at：Transcatheter Cardiovascular Therapeutics（TCT）meeting.October 29-November 2，2016，Washington，DC.
［15］Reichenspurner H，Schaefer A，Schäfer U，et al.Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Stenosis［J］.J Am Coll Cardiol，2017，70（25）：3127-3136.
［16］Möllmann H，Hengstenberg C，Hilker M，et al.Real-world experience using the Acurate neo prosthesis：30-day outcomes of 1，000 patients enrolled in the SAVI TF registry［J］.EuroIntervention，2018，13（15）：e1764-e1770.
［17］Makkar RR，Fontana G，Jilaihawi H，et al.Possible subclinical leaflet hrombosis in bioprosthetic aortic valves［J］.N Engl J Med，2015，373：2015-2024.
［18］Lefèvre T，Colombo A，Tchétché D，et al.Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System：12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis（DISCOVER）Study［J］.JACC Cardiovasc Interv，2016，9（1）：68-75.
［19］Asch FM，Vannan MA，Singh S，et al. Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk：An Analysis From the REPRISE Ⅲ Randomized Controlled Trial［J］.Circulation，2018，137（24）：2557-2567.